Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000791119 | SCV000930393 | uncertain significance | CHIME syndrome | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000791119 | SCV001369387 | uncertain significance | CHIME syndrome | 2019-10-30 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Labcorp Genetics |
RCV001873234 | SCV002189395 | uncertain significance | not provided | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with histidine at codon 88 of the PIGL protein (p.Arg88His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs755380500, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with PIGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 638452). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |